SEMMELWEIS UNIVERSITY, DEPARTMENT OF UROLOGY
TOPIC
Urology – Oncology of urothelial cancers and biomarkers for immunotherapy.
VISION
Optimize therapy for urothelial cancers.
MISSION
Leverage biomarkers in patients treated with immune checkpoint inhibitors.
PROJECT TITLE 1
Pre–treatment soluble PD–L1 as a predictor of overall survival with immune checkpoint inhibitor therapy: a systematic review and meta–analysis.
PROJECT TITLE 2
High pre–treatment sPD–L1 is associated with muscle invasion and shorter survival in UTUC: a post–hoc analysis of prospectively collected serum samples.
PROJECT TITLE 3
Prognostic significance of NLR, PLR, C–reactive protein, and LDH in urothelial cancer treated with immune checkpoint inhibitors: a systematic review and meta–analysis.